HRS-1893

· Shandong Suncadia Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for HRS-1893, covering 2024-10-30 to 2026-08-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy [Phase 3]